An important part of advancing medical research and drug development is making participation in clinical trials easier and more inclusive. To develop treatments that work on men, women, and children of all ages and different ethnicities we need to have clinical trial data that represents our diverse population. Right now, when the FDA approves a new drug we know that it will be effective in some – but not all …
Post Author: Belinda Tan, MD, PhD
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.